• PEOPLE
    Investment Team
    Ryan CarrRyan Carr
    Kerry Wate, CFAKerry Wate, CFA
    Brad Carter, CFABrad Carter, CFA
    Tim Vediz, CFATim Vediz, CFA
    Jesse SullivanJesse Sullivan
    Alexis  TakacsAlexis Takacs
    Rob MeussnerRob Meussner
    Business Team
    Neal WilkinsonNeal Wilkinson
    Susan  GurneySusan Gurney
    Lisa AyalaLisa Ayala
    Lenee FisherLenee Fisher
    Katie  PaolellaKatie Paolella
  • PRODUCTS
    US Small Cap Growth Equity
    Investment Team
    Philosophy/Process
    Performance
    Top Ten Holdings
    Sector Weightings
    Characteristics
    Statistics
    Product Profile
    Quarterly Commentary
  • PERFORMANCE
    US Small Cap Growth Equity
    Annual Performance
    Annualized Performance
    Rolling 3 Year Performance
    Product Profile
    Quarterly Commentary
    Performance Disclosure
  • FAST FACTS
    Asset Breakdown
    Minimum Account
    Investment Databases
    Privacy Statement
    Fee Schedule
    Product Profile
    Organization Chart

First

$25,000,000

1.00%

Next

$25,000,000

0.85%

Next

$50,000,000

0.80%

Excess over

$100,000,000

0.75%


Above is the standard fee schedule for seperate accounts.

Neal Wilkinson
CEO, MANAGING PARTNER


Performance shown is that of the Sparta US Small Cap Growth Equity Composite.  Past performance does not necessarily indicate how the Sparta US Small Cap Growth Equity Strategy will perform in the future.  Additional and more current performance is available at Annualized Performance.  Important disclosures about this performance information can be found by clicking on the following link,
Performance Disclosure.

Lenee Fisher
VICE PRESIDENT, OPERATIONS

Tim Vediz, CFA
VICE PRESIDENT, ANALYST

Susan Gurney
COO, PARTNER

Lisa Ayala
VICE PRESIDENT, ADMINISTRATOR

Kerry Wate, CFA
MANAGING DIRECTOR, PARTNER

Alexis Takacs
VICE PRESIDENT, OPERATIONS


Rubicon Technology Inc.
Onyx Pharmaceuticals Inc.
Rex Energy Corp.
Emulex Corp.
O2Micro International Ltd.
OM Group Inc.
Silicon Image Inc.
Wet Seal Inc.
Valmont Industries Inc.
Bio-Reference Laboratories Inc.


Total Weight of Top 10 = 35.06%

This supplemental information complements the US Small Cap Growth Equity Composite.  Please refer to the US Small Cap Growth Equity Disclosure by clicking on the following link, Performance Disclosure.


 

SCG

R2000G

Consumer Disc

9.4%

14.8%

Consumer Staples

0.0%

4.6%

Energy

 8.5%

7.7%

Financials

2.2%

7.9%

Healthcare

 18.4%

20.5%

Industrials 17.9% 15.9%
Information Tech 36.4% 23.3%
Materials 7.2% 4.0%
Telecom Services 0.0% 1.2%
Utilities  0.0%  0.1%


Source: FactSet
This supplemental information complements the US Small Cap Growth Equity Composite.  Please refer to the US Small Cap Growth Equity Disclosure by clicking on the following link,
Performance Disclosure.

 

 

SCG

R2000G

Number of Holdings

62

1141

Avg Mkt Cap ($B)

$0.787

$1.179

P/E (Trailing 1yr)

21.3

27.2

Return on Equity (%)

14.0

18.0

Dividend Yield (%)

0.33

0.78


Source: FactSet/Baseline/Russell
This supplemental information complements the US Small Cap Growth Equity Composite.  Please refer to the US Small Cap Growth Equity Disclosure by clicking on the following link,
Performance Disclosure. 

 

 

SCG

R2000G

Sharpe Ratio

0.09

0.08

Information Ratio

0.05

-

Standard Deviation (%)

23.59

23.49

Alpha

0.6

-

Beta

0.96

1.00

R-Squared (%)

0.91

1.00

 


Source: eVestment Alliance
This supplemental information complements the US Small Cap Growth Equity Composite.  Please refer to the US Small Cap Growth Equity Disclosure by clicking on the following link,Performance Disclosure.

 
Performance shown is that of the Sparta US Small Cap Growth Equity Composite.  Past performance does not necessarily indicate how the Sparta US Small Cap Growth Equity Strategy will perform in the future.  Additional and more current performance is available at
Annualized Performance.  Important disclosures about this performance information can be found by clicking on the following link,Performance Disclosure.


This supplemental information complements the US Small Cap Growth Equity Composite.  Periods shown are quarterly since inception (10/1/1995).  Rolling performance has been calculated on a 3 year basis rolling back quarterly.  Past performance is not indicative of future results.  Important disclosures about this performance information can be found by clicking on the following link, Performance Disclosure.

 

 

Separate Account: $10 Million

Collective Investment Trust: $1 Million

 

Separate Account: $10 Million

 

Firm and product information can be found on the following databases:


Altura Capital

Brockhouse & Cooper

Callan Associates

Cambridge Associates

CRA Rogers Casey

Evestment Alliance

LCG Associates

Mercer

Morningstar

Nelson Information

PSN Informais

Russell Mellon

Wilshire Odyssey

Zephyr Associates

Ryan Carr
CHIEF INVESTMENT OFFICER


Performance shown is that of the Sparta US Small Cap Growth Equity Composite.  Past performance does not necessarily indicate how the Sparta US Small Cap Growth Equity Strategy will perform in the future.  Important disclosures about this performance information can be found by clicking on the following link, Performance Disclosure.

Rob Meussner
ASSISTANT VICE PRESIDENT, ANALYST

 

 

Katie Paolella
ASSISTANT VICE PRESIDENT, OPERATIONS

Jesse Sullivan
MANAGING DIRECTOR, TRADING

Brad Carter, CFA
MANAGING DIRECTOR, SENIOR ANALYST

Copyright 2008-2011 Sparta

  • CONTACT US